Sumitomo Pharma Market Cap

Sumitomo Pharma has a market cap or net worth of $2.20 billion as of June 6, 2025. Its market cap has increased by 108.36% in one year.

Market Cap

2.20B

Enterprise Value

4.15B

Revenue

2.66B

Ranking

n/a

PE Ratio

13.97

Stock Price

$6.53

Market Cap Chart

Since January 14, 1992, Sumitomo Pharma's market cap has increased from 1.62B to 2.20B, an increase of 35.74%. That is a compound annual growth rate of 0.92%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2025	2.26B	58.75%
Dec 30, 2024	1.42B	8.36%
Dec 29, 2023	1.31B	-56.36%
Dec 30, 2022	3.01B	-34.17%
Dec 30, 2021	4.57B	-21.94%
Dec 30, 2020	5.86B	-24.66%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.60B
Veradigm	730.27M
Nika Pharmaceuticals	667.06M
Tian'an Technology Group	614.49M
Elite Pharmaceuticals	570.72M
Glass House Brands	444.38M
CytoDyn	430.80M
Northwest Biotherapeutics	392.36M

Market Cap Rankings